Hanmi, Eli Lilly Sign $1.26 Billion Licensing Agreement Business & Economy Hanmi, Eli Lilly Sign $1.26 Billion Licensing Agreement editor 6월 1, 2026 Hanmi Pharmaceutical headquarters in Seoul (Hanmi Pharmaceutical) Hanmi Pharmaceutical, a leading Korean drugmaker, announced a significant outlicensing...Read More
